SABC-HLP NETWORK
From embryo to stem cell cutting-egde technology
Southeast Asia is emerging as one of the world's most promising regions for Advanced Therapy Medicinal Products (ATMPs) and regenerative medicine, driven by growing healthcare demand, supportive regulatory frameworks, and expanding biotechnology investment.
Stem Cell Research & Therapy
Through its extensive network of international research collaborations and biomedical application partners, SABC aims to accelerate an integrated stem cell ecosystem SABC-HLP by connecting innovation, clinical translation, and industrial development.
Leveraging decades of technological expertise and a proven track record in advancing global milestones in cryopreservation, embryo technologies, cloning, and stem cell differentiation, SABC' ecosystem is focused on the international standardization of cell technologies and cell-based products, the establishment of comprehensive stem cell and biological specimen banking systems, and the transfer and commercialization of advanced cell and gene (C&G) technologies.
SABC Biobank
Technology Transfer
